9-[4-[4-(4-carbazol-9-ylphenyl)-6-phenyl-1,3-diaza-5-azanidacyclohexa-2,6-dien-2-yl]phenyl]carbazole
C45H30N5- — CID 143388767
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[4-[4-(4-carbazol-9-ylphenyl)-6-phenyl-1,3-diaza-5-azanidacyclohexa-2,6-dien-2-yl]phenyl]carbazole
9-[4-[4-(4-carbazol-9-ylphenyl)-6-phenyl-1,3-diaza-5-azanidacyclohexa-2,6-dien-2-yl]phenyl]carbazole (PubChem CID 143388767) has the molecular formula C45H30N5- and a molecular weight of 640.77 g/mol. Its IUPAC name is 9-[4-[4-(4-carbazol-9-ylphenyl)-6-phenyl-1,3-diaza-5-azanidacyclohexa-2,6-dien-2-yl]phenyl]carbazole.
Molecular Properties
| Compound Name | 9-[4-[4-(4-carbazol-9-ylphenyl)-6-phenyl-1,3-diaza-5-azanidacyclohexa-2,6-dien-2-yl]phenyl]carbazole |
|---|---|
| PubChem CID | 143388767 |
| Molecular Formula | C45H30N5- |
| Molecular Weight | 640.77 g/mol |
| Exact Mass | 640.25 |
| IUPAC Name | 9-[4-[4-(4-carbazol-9-ylphenyl)-6-phenyl-1,3-diaza-5-azanidacyclohexa-2,6-dien-2-yl]phenyl]carbazole |
| SMILES | c1ccc(C2=NC(c3ccc(-n4c5ccccc5c5ccccc54)cc3)=NC(c3ccc(-n4c5ccccc5c5ccccc54)cc3)[N-]2)cc1 |
| InChI | InChI=1S/C45H30N5/c1-2-12-30(13-3-1)43-46-44(31-22-26-33(27-23-31)49-39-18-8-4-14-35(39)36-15-5-9-19-40(36)49)48-45(47-43)32-24-28-34(29-25-32)50-41-20-10-6-16-37(41)38-17-7-11-21-42(38)50/h1-29,44H/q-1 |
| InChIKey | PIZRZIXLYIYZIJ-UHFFFAOYSA-N |
| XLogP | 11.16 |
| TPSA | 48.68 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 640.77 |
| LogP ≤ 5 | 11.16 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143388767 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.